Publication
HIV and Coronary Disease - When Secondary Prevention Is Insufficient
| dc.contributor.author | Carvalho, AS | |
| dc.contributor.author | Osório Valente, R | |
| dc.contributor.author | Almeida-Morais, L | |
| dc.contributor.author | Daniel, P | |
| dc.contributor.author | Sá Carvalho, R | |
| dc.contributor.author | Ferreira, L | |
| dc.contributor.author | Cruz Ferreira, R | |
| dc.date.accessioned | 2017-08-24T15:43:56Z | |
| dc.date.available | 2017-08-24T15:43:56Z | |
| dc.date.issued | 2017 | |
| dc.description.abstract | Highly active antiretroviral therapy (HAART) has created a new paradigm for human immunodeficiency virus (HIV)-infected patients, but their increased risk for coronary disease is well documented. We present the case of a 57-year-old man, co-infected with HIV-2 and hepatitis B virus, adequately controlled and with insulin-treated type 2 diabetes and dyslipidemia, who was admitted with non-ST elevation acute myocardial infarction. Coronary angiography performed on day four of hospital stay documented two-vessel disease (mid segment of the right coronary artery [RCA, 90% stenosis] and the first marginal). Two drug-eluting stents were successfully implanted. The patient was discharged under dual antiplatelet therapy (aspirin 100 mg/day and clopidogrel 75 mg/day) and standard coronary artery disease medication. He was admitted to the emergency room four hours after discharge with chest pain radiating to the left arm and inferior ST-segment elevation myocardial infarction was diagnosed. Coronary angiography was performed within one hour and documented thrombosis of both stents. Optical coherence tomography revealed good apposition of the stent in the RCA, with intrastent thrombus. Angioplasty was performed, with a good outcome. The acute stent thrombosis might be explained by the thrombotic potential of HIV infection and diabetes. There are no specific guidelines regarding HAART in secondary prevention of acute coronary syndromes. A multidisciplinary approach is essential for optimal management of these patients. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Rev Port Cardiol. 2017 Jul - Aug;36(7-8):569.e1-569.e8 | pt_PT |
| dc.identifier.doi | 10.1016/j.repc.2016.10.009 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.17/2741 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Elsevier España | pt_PT |
| dc.subject | HSM CAR | pt_PT |
| dc.subject | Antiretroviral Therapy, Highly Active | pt_PT |
| dc.subject | Coronary Thrombosis/etiology | pt_PT |
| dc.subject | Coronary Thrombosis/prevention & control | pt_PT |
| dc.subject | HIV Infections/complications | |
| dc.subject | HIV Infections/drug therapy | |
| dc.subject | Postoperative Complications/etiology | |
| dc.subject | Postoperative Complications/prevention & control | |
| dc.subject | Secondary Prevention | |
| dc.subject | Stents | |
| dc.title | HIV and Coronary Disease - When Secondary Prevention Is Insufficient | pt_PT |
| dc.title.alternative | VIH e Doença Coronária - Quando a Prevenção Secundária É Insuficiente | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 569.e8 | pt_PT |
| oaire.citation.issue | 7-8 | pt_PT |
| oaire.citation.startPage | 569.e1 | pt_PT |
| oaire.citation.title | Revista Portuguesa de Cardiologia (English Edition) | pt_PT |
| oaire.citation.volume | 36 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |